molecules-logo

Journal Browser

Journal Browser

Dendrimers as Nanocarriers for Drug Delivery

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (1 September 2019) | Viewed by 2936

Special Issue Editor


E-Mail Website
Guest Editor
Honorary Professor, UCL School of Pharmacy, 29/39 Brunswick Square, London, UK
Interests: computer-aided molecular design; molecular dynamics; computational chemistry; protein–ligand interactions; protein–excipient interactions; formulation design; NMR spectroscopy; antimicrobial peptide modelling
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear colleagues,

Medicines development research strives to improve drug efficacy and effectiveness via the optimization of drug delivery to achieve controlled release at the target site. The use of nanocarriers can improve the bioavailability of drugs and, at the same time, circumvent problems associated with their off-target interactions. These novel delivery systems offer opportunities to expand the spectrum of biomedical applications of molecules with poor drug-like properties.

Dendrimers, branched polymers with their highly tunable three-dimensional structure and modifiable surface functionalities, are attractive systems for drug delivery due to the possibility to build multifunctional nanocarriers for the targeted and smart release of the active pharmaceutical ingredient. The structure of the dendrimers can be varied to accommodate different molecules and/or to target different tissues, while the choice of monomers, number of generations, and surface modifications can be guided by computational chemistry approaches. Exploiting this versatile molecular architecture can unlock almost unlimited potential applications of dendrimers for the treatment of many diseases.

This Special Issue aims to attract contributions covering all fields concerning the development of dendrimers as nanocarriers, including the rational design of novel dendrimers as delivery systems, their synthesis with challenges in characterization, and their biomedical applications.

Honorary Prof. Dr. Mire Zloh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Dendrimers
  • Dendrons
  • Drug delivery
  • Drug encapsulation
  • Drug targeting
  • Dendrimer drug interactions
  • Controlled release
  • pH-responsive nanocarriers

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 1727 KiB  
Article
Stable Deuterium Labeling of Histidine-Rich Lysine-Based Dendrimers
by Nadezhda N. Sheveleva, Denis A. Markelov, Mikhail A. Vovk, Irina I. Tarasenko, Mariya E. Mikhailova, Maxim Yu Ilyash, Igor M. Neelov and Erkki Lahderanta
Molecules 2019, 24(13), 2481; https://doi.org/10.3390/molecules24132481 - 6 Jul 2019
Cited by 20 | Viewed by 2648
Abstract
Peptide dendrimers, due to their biocompatibility and low toxicity, are highly promising candidates as nanocarriers for drugs and genes. The development of this kind of delivery system requires reliable monitoring of their metabolic and biological pathways. In this respect, hydrogen isotope labeling has [...] Read more.
Peptide dendrimers, due to their biocompatibility and low toxicity, are highly promising candidates as nanocarriers for drugs and genes. The development of this kind of delivery system requires reliable monitoring of their metabolic and biological pathways. In this respect, hydrogen isotope labeling has tremendous importance, being a safe tool for detection of the labeled nanocarriers. In this work, we have synthesized new histidine-rich lysine-based dendrimers (Lys-2His dendrimer) with two linear histidine (His) residues in every inner segment. The presence of His residues has enabled us to perform controlled deuteration of Lys-2His dendrimers. The high deuteration degree (around 70%) does not practically change after redissolving the samples in H2O and heating them at 40 °C, which indicates the isotopic label stability. Full article
(This article belongs to the Special Issue Dendrimers as Nanocarriers for Drug Delivery)
Show Figures

Figure 1

Back to TopTop